{
    "nctId": "NCT05766891",
    "briefTitle": "Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery",
    "officialTitle": "Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 225,
    "primaryOutcomeMeasure": "Trait/State Anxiety Questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Men and Women;\n2. Age 18 or older;\n3. Diagnosed with stage 0/1 BCa;\n4. Scheduled for a unilateral, segmental mastectomy \u00b1 SLND\n5. Able to read, write and speak English or Spanish\n6. Able to sign a written informed consent and be willing to follow protocol requirements.\n\nExclusion Criteria:\n\n1. Extreme mobility issues that preclude participating in the study\n2. Major thought disorders such as schizophrenia or uncontrolled bipolar disorder or PTSD;\n3. Low score on Tellegen Absorption Scale (10 or below, a correlate of hypnotic suggestibility)\n4. History of chronic opioid use\n5. Current pain 2 or above on 0-10 scale\n6. Co-mobilities such as uncontrollable diabetes or hypertension\n7. Plastic surgery involvement for oncoplastic reconstruction\n8. Have undergone chemotherapy for current breast cancer diagnosis\n9. Surgery is likely greater than 3 hours\n10. Patients with hearing loss that could preclude HS facilitation\n11. Known allergy to propofol or other medications used during surgery",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}